NCT01749865

CIK Treatment for HCC Patient Underwent Radical Resection

A Randomized Controlled Study of Cytokine-induced Killer Cell (CIK) Treatment in Patients With Hepatocellular Carcinoma Who Underwent Radical Resection

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 200 (actual)
• Sponsor: Sun Yat-sen University · Academic / Other
• Sex: All
• Age: 18 Years – 100 Years
• Healthy volunteers: Not accepted

Summary

This is a randomized controlled study. About 200 patients with hepatocellular carcinoma who underwent radical resection will be included. The patients will be randomized to group A (receive CIK treatment) or group B (just regularly follow up) without any anti-cancer treatment after resection of HCC, and the randomize ratio will be 1:1.

Conditions

• Carcinoma, Hepatocellular

Interventions

Type	Name	Description
BIOLOGICAL	Cytokine-Induced Killer Cells	Cytokine-Induced Killer Cells treatment for 4 cycles

Timeline

• Start date: 2008-10-01
• Primary completion: 2014-09-01
• Completion: 2014-12-01
• First posted: 2012-12-17
• Last updated: 2016-04-14

Locations

1 site across 1 country: China